Regencell Bioscience stock surged 60,000% this year despite having no revenue

From Yahoo Finance: 2025-06-18 18:57:00

Regencell Bioscience’s stock has surged by nearly 60,000% this year, despite having no revenue. The Chinese herbal medicine company claims to have a formula to treat ADHD and autism, but it remains unprofitable. Shares quadrupled in a week, with a market cap of $30 billion. The CEO owns 86% of the company.

Regencell saw a 398% increase in its US-listed stock over two days. The firm offers a proprietary formula for ADHD and autism but has not made any revenue. The stock split on Monday saw the price soar by 283%. Retail investors are skeptical of the massive surge.

Regencell’s stock surge baffles investors as it reaches a market cap of $39 billion. Analysts speculate on Reddit about its status as a potential “meme stock.” The company’s formula claims to address neurocognitive disorders using natural ingredients.

Regencell’s CEO holds 86% of the company, with his net worth soaring to $33 billion. The company has only 30 million shares available for trading out of 500 million. Recent IPOs from Chinese and Hong Kong-based firms have faced scrutiny over potential fraud. Regulators warn of market manipulation risks.



Read more at Yahoo Finance: A Chinese herbal-medicine stock with no revenue has surged 60,000% this year. 5 things to know about the company’s mysterious spike.